{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910452693103321"]
[null,null,"Titolo",null,"Ataxia [[electronic resource] ] : causes, symptoms and treatment / / Sung Hoi Hong, editor"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Science Publishers, c2012"]
[null,null,"ISBN",null,"1-61942-869-5"]
[null,null,"Descrizione fisica",null,"1 online resource (213 p.)"]
[null,null,"Collana",null,"Neuroscience research progress"]
[null,null,"Soggetti",null,"Ataxia"]
[{"$nulls":4},"Movement disorders"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"ATAXIA \"\"; \"\"ATAXIA \"\"; \"\"CONTENTS \"\"; \"\"PREFACE \"\"; \"\"ROLE OF THE ATAXIA TELANGIECTASIA MUTATED PROTEIN IN STRESS-INDUCED  PREMATURE SENESCENCE \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION \"\"; \"\"ATM ACTIVATION \"\"; \"\"ATM SUBSTRATES \"\"; \"\"P53 STRUCTURE, ACTIVATION AND FUNCTION \"\"; \"\"ROLES OF ATM AND P53 IN DNA REPAIR\"\"; \"\"MULTIPLE FUNCTIONS OF P21 IN THE ATM NETWORK \"\"; \"\"SEQUENTIAL WAVES OF P53 ACTIVATION BY DNA DAMAGE \"\"; \"\"ATM-DEPENDENT SENESCENCE \"\"; \"\"ATM-INDEPENDENT SENESCENCE \"\"; \"\"ROLE OF ATM IN PREVENTING ESCAPE FROM SIPS: A NOVEL TUMOR SUPPRESSOR FUNCTION BEYOND P53? \"\""]
[{"$nulls":4},"\"\"POTENTIAL THERAPEUTIC APPROACHES FOR THE  TREATMENT OF AT \"\"\"\"CONCLUSION\"\"; \"\"ACKNOWLEDGMENTS \"\"; \"\"REFERENCES\"\"; \"\"ATAXIA TELANGIECTASIA: MOLECULAR BASIS, DIAGNOSIS AND TREATMENT \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION \"\"; \"\"CLINICAL FEATURES OF A-T \"\"; \"\"Neurological Phenotype and Cutaneous Manifestations \"\"; \"\"Immunodeficiency and Pulmonary Complications \"\"; \"\"Predisposition to Cancer and Chromosomal Instability\"\"; \"\"Endocrine Dysfunction \"\"; \"\"PATHOGENESIS AND MOLECULAR DEFECT \"\"; \"\"ATM and Neurodegeneration\"\"; \"\"ATM and Oxidative Stress \"\"; \"\"DIAGNOSIS AND TREATMENT \"\"; \"\"CONCLUSION \"\""]
[{"$nulls":4},"\"\"REFERENCES \"\"\"\"THE NEUROBIOLOGY OF EPISODIC ATAXIA TYPE 1, A SHAKER-LIKE K+ CHANNEL DISORDER \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION \"\"; \"\"STRUCTURE AND FUNCTION OF SHAKER-LIKE K+ CHANNELS \"\"; \"\"PHYSIOLOGICAL ROLE OF KV CHANNELS \"\"; \"\"Hippocampus \"\"; \"\"Cerebellum \"\"; \"\"Sciatic Nerve \"\"; \"\"BIOTECHNOLOGY "]
[{"$nulls":4},"FOR STUDYING ION CHANNELS \"\"; \"\"EPISODIC ATAXIA TYPE 1: \"\"; \"\"Clinical Findings \"\"; \"\"Genetic Causes \"\"; \"\"Molecular Pathogenetic Mechanisms Underlying EA1\"\"; \"\"Animal Models of EA1\"\"; \"\"Treatment of EA1 \"\"; \"\"BRIEF OVERVIEW OF RELATED ATAXIA DISORDERS \"\"; \"\"CONCLUSION \"\"; \"\"ACKNOWLEDGMENTS \"\""]
[{"$nulls":4},"\"\"REFERENCES \"\"\"\"MITOCHONDRIAL ATAXIAS \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION \"\"; \"\"ATAXIA IN MITOCHONDRIAL DISORDERS \"\"; \"\"MtDNA Point Mutations \"\"; \"\"MtDNA Sporadic Rearrangements \"\"; \"\"Infantile Onset Spinocerebellar Ataxia \"\"; \"\"POLG1-Related Diseases \"\"; \"\"OPA1-Related Diseases \"\"; \"\"Coenzyme Q10 Deficiency \"\"; \"\"FRIEDREICH ATAXIA \"\"; \"\"Mitochondrial Therapies for Friedreich Ataxia \"\"; \"\"MITOCHONDRIA AND OTHER GENETIC ATAXIAS \"\"; \"\"Dominant Spino-Cerebellar Ataxias \"\"; \"\"X-Linked Ataxias \"\"; \"\"CONCLUSION \"\"; \"\"REFERENCES \"\""]
[{"$nulls":4},"\"\"EPIDEMIC SEASONAL ATAXIC SYNDROME: EPIDEMIOLOGY, CLINICAL PRESENTATION, ETIOLOGICAL MECHANISMS AND THERAPY   \"\"\"\"ABSTRACT \"\"; \"\"INTRODUCTION \"\"; \"\"ETIOLOGY \"\"; \"\"Viral Hypothesis \"\"; \"\"Toxins in Food\"\"; \"\"Hypothesis of Thiamine Deficiency \"\"; \"\"CLINICAL PRESENTATION OF SAS IS COMPATIBLE WITH WERNICKEâ€?S ENCEPHALOPATHY \"\"; \"\"MECHANISM OF THIAMINE DEFICIENCY  IN SEASONAL ATAXIC SYNDROME \"\"; \"\"THERAPY AND CONTROL OF SAS \"\"; \"\"REFERENCES \"\"; \"\"CLINICAL AND GENETIC ASPECTS OF RECESSIVE ATAXIAS \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION \"\"; \"\"THE DEGENERATIVE ATAXIAS \"\"; \"\"Friedreichâ€?s Ataxia \"\""]
[{"$nulls":4},"\"\"Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) \"\""]